ClinicalTrials.gov
ClinicalTrials.gov Menu

Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00807755
Recruitment Status : Terminated (Number of known toxicities observed despite a treatment-naïve population)
First Posted : December 12, 2008
Last Update Posted : January 9, 2018
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
University of California, Davis

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : August 2010
  Actual Study Completion Date : December 2011